Topical 1% Voriconazole for Mixed Scedosporium and Exophiala Subcutaneous Infection in a Kidney Transplant Recipient

Authors

  • Olivier Paccoud Necker-Pasteur Center for Infectious Diseases and Tropical Medicine, Necker – Enfants Malades Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris Cité University, FR-75015 Paris, France
  • Pierre Sohier Department of Pathology, Cochin Hospital, AP-HP, Paris Cité University Paris Cité, 75014, Paris, France.
  • Camille Cotteret Pharmacy Department, Necker-Enfants Malades Hospital, AP-HP, 75015, Paris, France
  • Sarah Guégan Paris Cité University, Department of Dermatology, Cochin Hospital, AP-HP, 75014, Paris, France
  • Fanny Lanternier Necker-Pasteur Center for Infectious Diseases and Tropical Medicine, Necker – Enfants Malades Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris Cité University, FR-75015 Paris, France

DOI:

https://doi.org/10.2340/actadv.v103.9590

Keywords:

topical voriconazole, phaeohyphomycosis, hyalohyphomycosis, Scedosporium, Exophiala

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Guégan S, Garcia-Hermoso D, Sitbon K, Ahmed S, Moguelet P, Dromer F, et al. Ten-year experience of cutaneous and/or subcutaneous infections due to coelomycetes in France. Open Forum Infect Dis 2016; 3: ofw106.

https://doi.org/10.1093/ofid/ofw106 DOI: https://doi.org/10.1093/ofid/ofw106

Bouchand C, Nguyen D, Secretan PH, Vidal F, Guery R, Auvity S, et al. Voriconazole topical cream formulation: evidence for stability and antifungal activity. Int J Antimicrob Agents 2020; 56: 106083.

https://doi.org/10.1016/j.ijantimicag.2020.106083 DOI: https://doi.org/10.1016/j.ijantimicag.2020.106083

Chowdhary A, Meis JF, Guarro J, de Hoog GS, Kathuria S, Arendrup MC, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect 2014; 20: 47-75.

https://doi.org/10.1111/1469-0691.12515 DOI: https://doi.org/10.1111/1469-0691.12515

Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, Munoz P, et al. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect 2014; 20: 27-46.

https://doi.org/10.1111/1469-0691.12465 DOI: https://doi.org/10.1111/1469-0691.12465

Gülmez D, Doğan Ö, Boral B, Döğen A, İlkit M, de Hoog GS, et al. In vitro activities of antifungal drugs against environmental Exophiala isolates and review of the literature. Mycoses 2018; 61: 561-569.

https://doi.org/10.1111/myc.12779 DOI: https://doi.org/10.1111/myc.12779

Xing Y, Chen L, Feng Y, Zhou Y, Zhai Y, Lu J. Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections. BMC Infect Dis 2017; 17: 798.

https://doi.org/10.1186/s12879-017-2913-8 DOI: https://doi.org/10.1186/s12879-017-2913-8

Published

2023-06-15

How to Cite

Paccoud, O., Sohier, P., Cotteret, C., Guégan, S., & Lanternier, F. (2023). Topical 1% Voriconazole for Mixed Scedosporium and Exophiala Subcutaneous Infection in a Kidney Transplant Recipient. Acta Dermato-Venereologica, 103, adv9590. https://doi.org/10.2340/actadv.v103.9590

Issue

Section

Short Communication

Categories